{"id":227,"date":"2016-02-08T15:06:15","date_gmt":"2016-02-08T14:06:15","guid":{"rendered":"https:\/\/www.genoscreen.fr\/genomics-healthcare-nutrition\/"},"modified":"2026-06-10T11:50:16","modified_gmt":"2026-06-10T09:50:16","slug":"healthcare-nutrition","status":"publish","type":"page","link":"https:\/\/www.genoscreen.fr\/en\/healthcare-nutrition\/","title":{"rendered":"Healthcare & nutrition"},"content":{"rendered":"\n

Better understanding health through microorganism interactions<\/strong> is a key aspect of the One Health<\/strong> approach.<\/p>\n\n

\n
T\u00e9l\u00e9chargez notre brochure<\/a><\/div>\n\n\n\n
Contactez-nous pour plus d’informations<\/a><\/div>\n<\/div>\n\n

Whether it’s through studying the gut microbiome<\/strong> to develop innovative treatments or nutraceutical products, exploring specific diseases<\/strong> in clinical or preclinical studies, or addressing issues such as pathogenicity, virulence, antibiotic resistance, and the fight against multidrug-resistant infectious agents<\/strong>, scientific and regulatory requirements are becoming increasingly stringent.<\/p>\n\n

At GenoScreen, our goal is to turn science into tailored solutions that meet your specific needs<\/strong>, leveraging our expertise in genomics and microbiology.<\/p>\n\n

Genomics: A central component of future therapeutic and industrial innovation<\/h2>\n\n

Research teams are increasingly confronted with multifactorial and complex challenges in areas such as infectious diseases, gastrointestinal health, and oncology<\/strong>.\n<\/p>\n\n

Simultaneously, industrial stakeholders must ensure the safety, efficacy, and traceability of their products<\/strong>, underpinned by robust, auditable data fully aligned with international regulatory frameworks (GCLP<\/a>, GMP, EFSA<\/a>, Novel Food<\/a>).<\/div>\n\n\n
\n
Get started on your project by contacting our experts<\/a><\/div>\n<\/div>\n\n\n
\n
\n

Download the brochure<\/h3>\n\n\n